Follow this preprint
Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson’s disease
View ORCID ProfileJakub Kopal, View ORCID ProfileAndrew Vo, Qin Tao, View ORCID ProfileTanya Simuni, View ORCID ProfileLana M. Chahine, View ORCID ProfileDanilo Bzdok, View ORCID ProfileAlain Dagher
doi: https://doi.org/10.1101/2025.03.09.25323610
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Jakub Kopal
1Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
2Department of Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
Andrew Vo
3The Neuro - Montreal Neurological Institute and Hospital, McGill University, Montreal H3A 2B4, Canada
Qin Tao
3The Neuro - Montreal Neurological Institute and Hospital, McGill University, Montreal H3A 2B4, Canada
Tanya Simuni
4Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Lana M. Chahine
5Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA, 15213
Danilo Bzdok
2Department of Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
3The Neuro - Montreal Neurological Institute and Hospital, McGill University, Montreal H3A 2B4, Canada
6Mila - Quebec Artificial Intelligence Institute, Montréal, Quebec, Canada
Alain Dagher
3The Neuro - Montreal Neurological Institute and Hospital, McGill University, Montreal H3A 2B4, Canada
7Department of Neurology and neurosurgery, McGill University, Montréal, QC, Canada

Data Availability
Data used in the preparation of this article was obtained in May 2023 from the Parkinson's Progression Markers Initiative (PPMI) database (www.ppmi-info.org/access-data-specimens/download-data), RRID:SCR_006431. For up-to-date information on the study, visit www.ppmi-info.org.
Posted March 10, 2025.
Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson’s disease
Jakub Kopal, Andrew Vo, Qin Tao, Tanya Simuni, Lana M. Chahine, Danilo Bzdok, Alain Dagher
medRxiv 2025.03.09.25323610; doi: https://doi.org/10.1101/2025.03.09.25323610
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3183)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13160)
- Forensic Medicine (18)
- Gastroenterology (880)
- Genetic and Genomic Medicine (4995)
- Geriatric Medicine (460)
- Health Economics (765)
- Health Informatics (3145)
- Health Policy (1116)
- Hematology (418)
- HIV/AIDS (989)
- Medical Education (463)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4743)
- Nursing (253)
- Nutrition (702)
- Oncology (2439)
- Ophthalmology (692)
- Orthopedics (273)
- Otolaryngology (335)
- Pain Medicine (316)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1267)
- Primary Care Research (539)
- Public and Global Health (7308)
- Radiology and Imaging (1641)
- Respiratory Medicine (956)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)